HLA-DOA Human (+)-catechin multiple interactions EXP 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of HLA-DOA mRNA CTD PMID:24763279 HLA-DOA Human 1,2-dimethylhydrazine increases expression ISO H2-Oa (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of H2-OA mRNA CTD PMID:22206623 HLA-DOA Human 1-naphthyl isothiocyanate decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of RT1-DOA mRNA CTD PMID:30723492 HLA-DOA Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO H2-Oa (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of H2-OA mRNA CTD PMID:21041162 HLA-DOA Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO H2-Oa (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of H2-OA mRNA CTD PMID:26377647 HLA-DOA Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO H2-Oa (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of H2-OA mRNA CTD PMID:28213091 HLA-DOA Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HLA-DOA mRNA CTD PMID:21296121 HLA-DOA Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of HLA-DOA mRNA CTD PMID:37199045 HLA-DOA Human 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bisphenol S results in decreased methylation of HLA-DOA gene CTD PMID:31601247 HLA-DOA Human 4,4'-sulfonyldiphenol multiple interactions ISO RT1-DOa (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RT1-DOA mRNA CTD PMID:36041667 HLA-DOA Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol S co-treated with Fulvestrant] results in decreased methylation of HLA-DOA gene CTD PMID:31601247 HLA-DOA Human acetamide increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 acetamide results in increased expression of RT1-DOA mRNA CTD PMID:31881176 HLA-DOA Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of HLA-DOA mRNA CTD PMID:38460933 HLA-DOA Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of HLA-DOA mRNA CTD PMID:21641981 HLA-DOA Human alpha-Zearalanol increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Zeranol results in increased expression of RT1-DOA mRNA CTD PMID:35163327 HLA-DOA Human amphetamine decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of RT1-DOA mRNA CTD PMID:30779732 HLA-DOA Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of HLA-DOA mRNA CTD PMID:24449571 HLA-DOA Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of HLA-DOA mRNA CTD PMID:33212167 HLA-DOA Human benzalkonium chloride affects response to substance EXP 6480464 HLA-DOA SNP affects the susceptibility to Benzalkonium Compounds CTD PMID:27258892 HLA-DOA Human benzo[a]pyrene decreases expression ISO H2-Oa (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of H2-OA mRNA CTD PMID:21569818 HLA-DOA Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of HLA-DOA promoter CTD PMID:27901495 HLA-DOA Human benzo[a]pyrene multiple interactions ISO H2-Oa (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA CTD PMID:27858113 HLA-DOA Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of HLA-DOA mRNA CTD PMID:21871943 HLA-DOA Human benzo[b]fluoranthene multiple interactions ISO H2-Oa (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA CTD PMID:27858113 HLA-DOA Human bisphenol A decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of HLA-DOA mRNA CTD PMID:25181051 HLA-DOA Human bisphenol A multiple interactions ISO RT1-DOa (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RT1-DOA mRNA CTD PMID:36041667 HLA-DOA Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-DOA gene CTD PMID:31601247 HLA-DOA Human bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HLA-DOA gene CTD PMID:31601247 HLA-DOA Human bisphenol F multiple interactions ISO RT1-DOa (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RT1-DOA mRNA CTD PMID:36041667 HLA-DOA Human bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of HLA-DOA mRNA CTD PMID:20977926 HLA-DOA Human buta-1,3-diene decreases expression ISO H2-Oa (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of H2-OA mRNA CTD PMID:29038090 HLA-DOA Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of HLA-DOA mRNA CTD PMID:26079696 HLA-DOA Human cadmium dichloride decreases methylation ISO RT1-DOa (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased methylation of RT1-DOA promoter CTD PMID:22457795 HLA-DOA Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HLA-DOA mRNA CTD PMID:38382870 HLA-DOA Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of HLA-DOA mRNA CTD PMID:25811541 and PMID:25979313 HLA-DOA Human carbon nanotube affects expression ISO H2-Oa (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of H2-OA mRNA CTD PMID:25554681 HLA-DOA Human carbon nanotube decreases expression ISO H2-Oa (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of H2-OA mRNA CTD PMID:25554681 HLA-DOA Human cefazolin affects expression EXP 6480464 Cefazolin affects the expression of HLA-DOA mRNA CTD PMID:25811541 HLA-DOA Human chloroprene decreases expression ISO H2-Oa (Mus musculus) 6480464 Chloroprene results in decreased expression of H2-OA mRNA CTD PMID:23125180 HLA-DOA Human chrysene multiple interactions ISO H2-Oa (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA CTD PMID:27858113 HLA-DOA Human dexamethasone decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of RT1-DOA mRNA CTD PMID:14618091 HLA-DOA Human dexamethasone increases expression ISO H2-Oa (Mus musculus) 6480464 Dexamethasone results in increased expression of H2-OA mRNA CTD PMID:21041162 HLA-DOA Human dimethylarsinic acid multiple interactions ISO H2-Oa (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA CTD PMID:34876320 HLA-DOA Human dioxygen multiple interactions ISO H2-Oa (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2-OA mRNA CTD PMID:30529165 HLA-DOA Human diquat decreases expression ISO H2-Oa (Mus musculus) 6480464 Diquat results in decreased expression of H2-OA mRNA CTD PMID:36851058 HLA-DOA Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 HLA-DOA Human entinostat increases expression EXP 6480464 entinostat results in increased expression of HLA-DOA mRNA CTD PMID:27188386 HLA-DOA Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-DOA gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of HLA-DOA gene CTD PMID:31601247 HLA-DOA Human gefitinib affects expression EXP 6480464 gefitinib affects the expression of HLA-DOA mRNA CTD PMID:25811541 HLA-DOA Human gentamycin increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Gentamicins results in increased expression of RT1-DOA mRNA CTD PMID:33387578 HLA-DOA Human indapamide affects expression EXP 6480464 Indapamide affects the expression of HLA-DOA mRNA CTD PMID:25811541 HLA-DOA Human lead diacetate decreases expression ISO H2-Oa (Mus musculus) 6480464 lead acetate results in decreased expression of H2-OA mRNA CTD PMID:21829687 HLA-DOA Human lead(0) decreases expression EXP 6480464 Lead results in decreased expression of HLA-DOA mRNA CTD PMID:19921347 HLA-DOA Human mercury dibromide decreases expression EXP 6480464 mercuric bromide results in decreased expression of HLA-DOA mRNA CTD PMID:26272509 HLA-DOA Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DOA mRNA CTD PMID:27188386 HLA-DOA Human methylarsonic acid multiple interactions ISO H2-Oa (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA CTD PMID:34876320 HLA-DOA Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of HLA-DOA mRNA CTD PMID:28001369 HLA-DOA Human nitrobenzenes increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Nitrobenzenes analog results in increased expression of RT1-DOA mRNA CTD PMID:19784758 HLA-DOA Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of HLA-DOA mRNA CTD PMID:38460933 HLA-DOA Human ozone multiple interactions ISO H2-Oa (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of H2-OA mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of H2-OA mRNA CTD PMID:34911549 HLA-DOA Human p-chloromercuribenzoic acid decreases expression EXP 6480464 p-Chloromercuribenzoic Acid results in decreased expression of HLA-DOA mRNA CTD PMID:26272509 HLA-DOA Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DOA mRNA CTD PMID:27188386 HLA-DOA Human paracetamol increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of RT1-DOA mRNA CTD PMID:19784758 HLA-DOA Human paracetamol decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of RT1-DOA mRNA CTD PMID:19784758 HLA-DOA Human paraquat decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Paraquat results in decreased expression of RT1-DOA mRNA CTD PMID:32680482 HLA-DOA Human pentanal increases expression EXP 6480464 pentanal results in increased expression of HLA-DOA mRNA CTD PMID:26079696 HLA-DOA Human phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of HLA-DOA mRNA CTD PMID:26272509 HLA-DOA Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DOA mRNA CTD PMID:27188386 HLA-DOA Human pirinixic acid increases expression ISO H2-Oa (Mus musculus) 6480464 pirinixic acid results in increased expression of H2-OA mRNA CTD PMID:20813756 HLA-DOA Human propanal increases expression EXP 6480464 propionaldehyde results in increased expression of HLA-DOA mRNA CTD PMID:26079696 HLA-DOA Human saquinavir affects expression EXP 6480464 Saquinavir affects the expression of HLA-DOA mRNA CTD PMID:25811541 HLA-DOA Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 HLA-DOA Human silicon dioxide increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of RT1-DOA mRNA CTD PMID:32721576 HLA-DOA Human sodium arsenate multiple interactions ISO H2-Oa (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA CTD PMID:34876320 HLA-DOA Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HLA-DOA mRNA CTD PMID:38568856 HLA-DOA Human sodium arsenite multiple interactions ISO H2-Oa (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA CTD PMID:34876320 HLA-DOA Human sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of HLA-DOA gene CTD PMID:28589171 HLA-DOA Human tetraphene increases expression ISO H2-Oa (Mus musculus) 6480464 benz(a)anthracene results in increased expression of H2-OA mRNA CTD PMID:26377693 HLA-DOA Human tetraphene multiple interactions ISO H2-Oa (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA CTD PMID:27858113 HLA-DOA Human thioacetamide increases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of RT1-DOA mRNA CTD PMID:19784758 HLA-DOA Human titanium dioxide decreases expression ISO H2-Oa (Mus musculus) 6480464 titanium dioxide results in decreased expression of H2-OA mRNA CTD PMID:27760801 and PMID:35295148 HLA-DOA Human titanium dioxide increases expression ISO H2-Oa (Mus musculus) 6480464 titanium dioxide results in increased expression of H2-OA mRNA CTD PMID:23557971 HLA-DOA Human trichloroethene increases expression ISO H2-Oa (Mus musculus) 6480464 Trichloroethylene results in increased expression of H2-OA mRNA CTD PMID:15363585 HLA-DOA Human trichloroethene decreases expression ISO RT1-DOa (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of RT1-DOA mRNA CTD PMID:33387578 HLA-DOA Human trichloroethene multiple interactions ISO H2-Oa (Mus musculus) 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of H2-OA protein] CTD PMID:15363585 HLA-DOA Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of HLA-DOA mRNA CTD PMID:37042841 HLA-DOA Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HLA-DOA mRNA CTD PMID:28001369
